Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02449239
Title Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG
Acronym VISTA
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Viventia Bio
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.